CD147 supports paclitaxel resistance via interacting with RanBP1

Though the great success of paclitaxel, the variable response of patients to the drug limits its clinical utility and the precise mechanisms underlying the variable response to paclitaxel remain largely unknown. This study aims to verify the role and the underlying mechanisms of CD147 in paclitaxel...

Descripción completa

Detalles Bibliográficos
Autores principales: Nan, Gang, Zhao, Shu-Hua, Wang, Ting, Chao, Dong, Tian, Ruo-Fei, Wang, Wen-Jing, Fu, Xin, Lin, Peng, Guo, Ting, Wang, Bin, Sun, Xiu-Xuan, Chen, Xi, Chen, Zhi-Nan, Wang, Shi-Jie, Cui, Hong-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837534/
https://www.ncbi.nlm.nih.gov/pubmed/34974521
http://dx.doi.org/10.1038/s41388-021-02143-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837534/
https://www.ncbi.nlm.nih.gov/pubmed/34974521
http://dx.doi.org/10.1038/s41388-021-02143-3

Ejemplares similares